Long-Term Safety and Efficacy of rFIXFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia B

Completed · Phase 3

Conditions studied: Severe Hemophilia B

In brief

The primary objective of the study is to evaluate the long-term safety of rFIXFc in participants with hemophilia B. The secondary objective of this study is to evaluate the efficacy of rFIXFc in the prevention and treatment of bleeding episodes.

Key facts

Study ID

NCT01425723

Run by

Bioverativ Therapeutics Inc.

People needed

120

Starts

2011-12-08

Expected to finish

2017-10-01

Last updated by the study team

2020-12-19

Who can join

Age: any. Sex: male. Healthy volunteers: not accepted.

Where it is running

• Research Site — Phoenix, Arizona, United States
• Research Site — Sacramento, California, United States
• Research Site — Aurora, Colorado, United States
• Research Site — Atlanta, Georgia, United States
• Research Site — Honolulu, Hawaii, United States
• Research Site — Indianapolis, Indiana, United States
• Research Site — New Orleans, Louisiana, United States
• Research Site — East Lansing, Michigan, United States
• Research Site — Pittsburgh, Pennsylvania, United States
• Research Site — Seattle, Washington, United States
• Research Site — Adelaide, South Australia, Australia
• Research site — Parkville, Victoria, Australia
• Research site — Murdoch, Western Australia, Australia
• Research Site — Perth, Western Australia, Australia
• Research Site — Brussels, Belgium
• Research Site — Leuven, Belgium
• Research Site — Campinas, São Paulo, Brazil
• Research Site — Toronto, Ontario, Canada
• Research Site — Montreal, Quebec, Canada
• Research Site — Beijing, Beijingshì, China
• Research Site — Guangzhou, Guangdongsheng, China
• Research Site — Shanghai, Shànghaishì, China
• Research Site — Tianjing, Tianjinshì, China
• Research Site — Marseille, Bouches-Du-Rhône, France
• Research Site — Bonn, North Rhine-Westphalia, Germany

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.